News
Stocktwits on MSN9h
Novavax Wins FDA Approval For COVID-19 Vaccine: Retail Calls For Buyback And Bigger MovesNovavax Inc. drew retail attention on Friday after receiving a Biologics License Application for its COVID-19 vaccine, ...
Vietnam Investment Review on MSN2h
AIM Vaccine's Next-Gen mRNA Shingles Vaccine Secures Clinical Approvals in Both PRC and U.S. ,mRNA Platform Advantages Shine ThroughWhile global giants like Moderna and BioNTech apply mRNA technology to broader disease markets, PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660.HK), a leading domestic vaccine company, ...
A new study from the European Society of Cardiology found that receiving the shingles vaccine can lower the risk of heart ...
The new vaccine type can potentially provide safer, more targeted treatment with fewer side effects than existing therapies ...
recombinant vaccines. The United States is among the countries that use the new vaccine, Shingrix, which was introduced in 2017. The vaccine, manufactured by GlaxoSmithKline, is more than 90% ...
People who receive the shingles vaccine have a 23% lower risk of cardiovascular events, such as stroke, and coronary heart ...
Vaxart gets BARDA nod to begin dosing in 10,000-participant portion of phase 2b Covid-19 clinical trial: South San Francisco, California Saturday, May 17, 2025, 18:00 Hrs [IST] Va ...
Shingles is a viral infection that causes painful rashes. While shingles can occur anywhere on the body, it typically looks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback